Diabetic macular edema Trials in Huntington Beach, United States
Conditions / Diabetic macular edema / Huntington Beach, United States
Research into Diabetic macular edema spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05727891 | Evaluation of Tonabersat for DME | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06172257 | A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) | COMPLETED | — |
| NCT05063734 | A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. | TERMINATED | PHASE2 |
| NCT04527107 | A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema | COMPLETED | PHASE2 |
| NCT04429503 | Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease | COMPLETED | PHASE2/PHASE3 |
| NCT01945866 | Phase II Combination Steroid and Anti-VEGF for Persistent DME | COMPLETED | PHASE2 |
| NCT06011798 | Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE) | COMPLETED | PHASE2 |
| NCT02634333 | Anti-VEGF Treatment for Prevention of PDR/DME | COMPLETED | PHASE3 |
| NCT03917472 | Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema | COMPLETED | PHASE3 |
| NCT03345901 | PROMINENT-Eye Ancillary Study (Protocol AD) | TERMINATED | PHASE3 |